FindTrial
Sign In

ASP3652

DRUG8 trials

Sponsors

Astellas Pharma Inc, Astellas Pharma Europe B.V.

Conditions

Chronic Abacterial ProstatitisChronic Pelvic Pain SyndromeCystitis, InterstitialDrug-Drug Interaction (DDI)Effect of RaceHealthy SubjectsPainPharmacodynamics

Phase 1

A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects
CompletedNCT01797198
Astellas Pharma Europe B.V.Drug-Drug Interaction (DDI), Healthy Subjects
Start: 2012-04-30End: 2012-06-30Updated: 2013-02-22
A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects
CompletedNCT01815684
Astellas Pharma Europe B.V.Healthy Subjects, Pharmacodynamics, Pharmacokinetics +1
Start: 2012-08-31End: 2012-12-31Updated: 2013-03-21
A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability
CompletedNCT01958047
Astellas Pharma Europe B.V.Effect of Race, Healthy Subjects, Pharmacodynamics +1
Start: 2012-07-31End: 2012-09-30Updated: 2013-10-08
A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male Subjects
CompletedNCT02034734
Astellas Pharma Europe B.V.Healthy Subjects, Pharmacodynamics of ASP3652, Pharmacokinetics of ASP3652
Start: 2012-09-30End: 2012-12-31Updated: 2014-01-13
A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652
CompletedNCT02046798
Astellas Pharma Europe B.V.Healthy Subjects, Pharmacokinetics of ASP3652
Start: 2012-07-31End: 2012-08-31Updated: 2014-01-28
A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652
CompletedNCT02243657
Astellas Pharma Europe B.V.Healthy Subjects, Pharmacodynamics of ASP3652, Pharmacokinetics of ASP3652
Start: 2009-05-31End: 2010-05-31Updated: 2014-09-18

Phase 2

A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
CompletedNCT01391338
Astellas Pharma IncChronic Abacterial Prostatitis, Chronic Pelvic Pain Syndrome
Start: 2011-06-30End: 2013-02-28Updated: 2013-03-21
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
CompletedNCT01613586
Astellas Pharma Europe B.V.Cystitis, Interstitial, Pain, Urinary Bladder Disease +1
Start: 2012-05-31End: 2014-03-18Updated: 2024-11-05

Related Papers

Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels.
2020-07-26